Literature DB >> 3154025

Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor.

S Nozawa1, K Tsukazaki, M Sakayori, C H Jeng, R Iizuka.   

Abstract

A cell line, designated RMG-I, has been established from ascites of a patient with ovarian clear cell carcinoma. RMG-I cells have grown well for more than 6 years with mirror ball formation. Chromosome analysis revealed aneuploidy with a modal number of 47 and 3 marker chromosomes. The histological characteristics of the transplanted tumor were similar to those observed in the original tumor which was composed of dark cells, clear cells, and hobnail cells. Thus, the RMG-I cell line was identified to be an ovarian clear cell carcinoma. Immunohistochemically, basic fetoprotein (BFP) and ferritin were demonstrated in the original tumor, the cultured cells, and the transplanted tumor. Furthermore, in order to clarify whether these 3 kinds of cells originate from one stem cell or not, monoclonal cell population were transplanted into nude mice, and its histological investigation revealed that 3 types of cells existed in the transplanted tumor, proving that they originate from one stem cell.

Entities:  

Mesh:

Year:  1988        PMID: 3154025

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  22 in total

1.  The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II.

Authors:  Marco Trizzino; Elisa Barbieri; Ana Petracovici; Shuai Wu; Sarah A Welsh; Tori A Owens; Silvia Licciulli; Rugang Zhang; Alessandro Gardini
Journal:  Cell Rep       Date:  2018-06-26       Impact factor: 9.423

2.  A patient-like orthotopic implantation nude mouse model of highly metastatic human ovarian cancer.

Authors:  K Kiguchi; T Kubota; D Aoki; Y Udagawa; S Yamanouchi; M Saga; A Amemiya; F X Sun; S Nozawa; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

3.  Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.

Authors:  Daisuke Aoki; Nao Suzuki; Nobuyuki Susumu; Tomomi Noda; Atsushi Suzuki; Yutaka Tamada; Atsushi Higashiguchi; Shinji Oie; Shiro Nozawa
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

4.  Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.

Authors:  Nao Suzuki; Atsushi Higashiguchi; Yuko Hasegawa; Hiroshi Matsumoto; Shinji Oie; Kimiko Orikawa; Sachiko Ezawa; Nobuyuki Susumu; Ki-Ichi Miyashita; Daisuke Aoki
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

5.  Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells.

Authors:  Kyoko Tanaka; Kazushige Kiguchi; Mikio Mikami; Daisuke Aoki; Masao Iwamori
Journal:  Hum Cell       Date:  2019-07-26       Impact factor: 4.174

6.  Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells.

Authors:  Song Gao; Qing Liu; Xinyan Wang; Bei Lin; Shulan Zhang
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

7.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

8.  Potential role of mTORC2 as a therapeutic target in clear cell carcinoma of the ovary.

Authors:  Takeshi Hisamatsu; Seiji Mabuchi; Yuri Matsumoto; Mahiru Kawano; Tomoyuki Sasano; Ryoko Takahashi; Kenjiro Sawada; Kimihiko Ito; Hirohisa Kurachi; Russell J Schilder; Joseph R Testa; Tadashi Kimura
Journal:  Mol Cancer Ther       Date:  2013-04-24       Impact factor: 6.261

9.  Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines.

Authors:  Yoshiaki Okuma; Kazushige Kiguchi; Yutaka Koshitaka; Asami Okamura; Isamu Ishiwata; Haruhiro Kondo; Bunpei Ishizuka; Mamoru Tadokoro
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

10.  Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.

Authors:  Akihiro Ohyama; Junko Toyomura; Toshiaki Tachibana; Seiji Isonishi; Haruka Takahashi; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2016-08-19       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.